Adjuvant trastuzumab improves survival in early breast cancer

被引：1
|
作者：
Brower, Vicki
机构：
来源：
LANCET ONCOLOGY | 2014年 / 15卷 / 13期
关键词：
D O I：
10.1016/S1470-2045(14)71110-6
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：E589 / E589
页数：1
相关论文
共 50 条
  • [41] Adjuvant radiotherapy for breast cancer significantly improves overall survival: the missing link
    Van de Steene, J
    Soete, G
    Storme, G
    RADIOTHERAPY AND ONCOLOGY, 2000, 55 (03) : 263 - 272
  • [42] Adjuvant breast cancer vaccine improves overall survival of patients with depressed immunity
    Head, Jonathan F.
    Elliott, Robert L.
    CANCER RESEARCH, 2012, 72
  • [43] Survival in patients with non-metastatic breast cancer treated with adjuvant trastuzumab in clinical practice
    Gallagher, Christopher M.
    More, Kenneth
    Masaquel, Anthony
    Kamath, Tripthi
    Guerin, Annie
    Ionescu-Ittu, Raluca
    Nitulescu, Roy
    Gauthier-Loiselle, Marjolaine
    Sicignano, Nicholas
    Butts, Elizabeth
    Wu, Eric Q.
    Barnett, Brian
    SPRINGERPLUS, 2016, 5
  • [44] Adjuvant docetaxel or vinorelbine with or without trastuzumab for breast cancer
    Joensuu, H
    Kellokumpu-Lehtinen, P
    Bono, P
    Alanko, T
    Kataja, V
    Asola, R
    Utriainen, T
    Kokko, R
    Hemminki, A
    Tarkkanen, M
    Turpeenniemi-Hujanen, T
    Jyrkkiö, S
    Flander, M
    Helle, L
    Ingalsuo, S
    Johansson, K
    Jääskeläinen, A
    Pajunen, M
    Rauhala, M
    Kaleva-Kerola, J
    Salminen, T
    Leinonen, M
    Elomaa, I
    Isola, J
    NEW ENGLAND JOURNAL OF MEDICINE, 2006, 354 (08): : 809 - 820
  • [45] Adjuvant Short-Course Trastuzumab in Breast Cancer
    Sethjiwala, Taha
    Dhanushkodi, Manikandan
    Radhakrishnan, Venkatraman
    Kalaiarasi, Jayachandran Perumal
    Mehra, Nikita
    Joshi, Archit
    Rajan, Arun Kumar
    Selvarajan, Gangothri
    Ananthi, Balasubramanian
    Iyer, Priya
    Senguttuvan, Geetha
    Srilatha, Bharathi
    Ranganathan, Rama
    Sundersingh, Shirley
    Krishnamurthy, Arvind
    Velusamy, Sridevi
    Raj, Hemanth
    Ganesarajah, Selvaluxmy
    Sagar, Tenali Gnana
    Ganesan, Trivadi S.
    INDIAN JOURNAL OF GYNECOLOGIC ONCOLOGY, 2019, 17 (03)
  • [46] Substituting adjuvant trastuzumab emtansine for Herceptin improves survival in patients with human epidermal growth factor receptor 2-positive breast cancer
    Printz, Carrie
    CANCER, 2019, 125 (08) : 1213 - 1213
  • [47] Adjuvant trastuzumab for breast cancer - The other side of the coin
    Gopalakrishnan, S
    Linnane, J
    BMJ-BRITISH MEDICAL JOURNAL, 2005, 331 (7526): : 1202 - 1203
  • [48] Adjuvant Short-Course Trastuzumab in Breast Cancer
    Taha Sethjiwala
    Manikandan Dhanushkodi
    Venkatraman Radhakrishnan
    Jayachandran Perumal Kalaiarasi
    Nikita Mehra
    Archit Joshi
    Arun Kumar Rajan
    Gangothri Selvarajan
    Balasubramanian Ananthi
    Priya Iyer
    Geetha Senguttuvan
    Bharathi Srilatha
    Rama Ranganathan
    Shirley Sundersingh
    Arvind Krishnamurthy
    Sridevi Velusamy
    Hemanth Raj
    Selvaluxmy Ganesarajah
    Tenali Gnana Sagar
    Trivadi S. Ganesan
    Indian Journal of Gynecologic Oncology, 2019, 17
  • [49] Implementation of adjuvant trastuzumab in breast cancer patients in the Netherlands
    de Munck, L.
    Schaapveld, M.
    Siesling, S.
    Otter, R.
    Willemse, P. H. B.
    EJC SUPPLEMENTS, 2010, 8 (03): : 69 - 69
  • [50] Rationale for trastuzumab (Herceptin) in adjuvant breast cancer trials
    Slamon, D
    Pegram, M
    SEMINARS IN ONCOLOGY, 2001, 28 (01) : 13 - 19
12345